esophageal squamous cell carcinoma

You have access
Intraoperative Blood Loss Impacts Recurrence and Survival in Patients With Locally Advanced Esophageal Cancer
HAYATO WATANABE, KAZUKI KANO, ITARU HASHIMOTO, MIE TANABE, SHIZUNE ONUMA, JUNYA MORITA, SHINSUKE NAGASAWA, KYOHEI KANEMATSU, TORU AOYAMA, TAKANOBU YAMADA, TAKASHI OGATA, YASUSHI RINO, AYA SAITO and TAKASHI OSHIMA

Anticancer Research November 2023, 43 (11) 5173-5179; DOI: https://doi.org/10.21873/anticanres.16718
You have access
Additional Effects of Docetaxel on Neoadjuvant Radiotherapy With Cisplatin/5-Fluorouracil for Esophageal Squamous Cell Carcinoma
KEN SASAKI, YUSUKE TSURUDA, MASATAKA SHIMONOSONO, MASAHIRO NODA, YASUTO UCHIKADO, TAKAAKI ARIGAMI, DAISUKE MATSUSHITA, SHINICHIRO MORI, AKIHIRO NAKAJO, HIROSHI KURAHARA and TAKAO OHTSUKA

Anticancer Research August 2022, 42 (8) 3905-3911; DOI: https://doi.org/10.21873/anticanres.15884
You have access
Chlorogenic Acid Inhibition of Esophageal Squamous Cell Carcinoma Metastasis via EGFR/p-Akt/Snail Signaling Pathways
YU-KUEI CHEN, NGO TRAN MY NGOC, HSI-WEN CHANG, YING-FANG SU, CHUNG-HWAN CHEN, YIH-GANG GOAN, JEFF YI-FU CHEN, CHUN-WEI TUNG and TZYH-CHYUAN HOUR

Anticancer Research July 2022, 42 (7) 3389-3402; DOI: https://doi.org/10.21873/anticanres.15826
Open Access
Neutrophil-to-Lymphocyte Ratio to Predict the Efficacy of Immune Checkpoint Inhibitor in Upper Gastrointestinal Cancer
EISUKE BOOKA, HIROTOSHI KIKUCHI, RYOMA HANEDA, WATARU SONEDA, SANSHIRO KAWATA, TOMOHIRO MURAKAMI, TOMOHIRO MATSUMOTO, YOSHIHIRO HIRAMATSU and HIROYA TAKEUCHI

Anticancer Research June 2022, 42 (6) 2977-2987; DOI: https://doi.org/10.21873/anticanres.15781
You have access
Impact of the Platelet-to-Lymphocyte Ratio as a Biomarker for Esophageal Squamous Cell Carcinoma
TAKASHI KATO, TARO OSHIKIRI, HIRONOBU GOTO, RYUICHIRO SAWADA, HITOSHI HARADA, NAOKI URAKAWA, HIROSHI HASEGAWA, SHINGO KANAJI, KIMIHIRO YAMASHITA, TAKERU MATSUDA and YOSHIHIRO KAKEJI

Anticancer Research May 2022, 42 (5) 2775-2782; DOI: https://doi.org/10.21873/anticanres.15757
You have access
ypN0 in Patients With Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer
TAKAHIRO YOSHIDA, TAKESHI NISHINO, MASAKAZU GOTO, SEIYA INOUE, SATOSHI FUJIWARA, HIROMITSU TAKIZAWA, AKIRA TANGOKU, HISANORI UEHARA and YOSHIMI BANDO

Anticancer Research January 2022, 42 (1) 195-203; DOI: https://doi.org/10.21873/anticanres.15473
You have access
SF3B4 Plays an Oncogenic Role in Esophageal Squamous Cell Carcinoma
SHINYA KIDOGAMI, TOMOHIRO IGUCHI, KUNIAKI SATO, YUKIHIRO YOSHIKAWA, QUINGJANG HU, SHO NAMBARA, HISATERU KOMATSU, MASAMI UEDA, YOSUKE KURODA, TAKAAKI MASUDA, MASAKI MORI, YUICHIRO DOKI and KOSHI MIMORI

Anticancer Research May 2020, 40 (5) 2941-2946; DOI: https://doi.org/10.21873/anticanres.14272
You have access
Role of FOXO3A in Trastuzumab Combination Chemotherapy in Esophageal Squamous Cell Carcinoma
MASASHI TAKAHASHI, KAZUMASA FUKUDA, YOSHIRO SAIKAWA, RIEKO NAKAMURA, NORIHITO WADA, HIROFUMI KAWAKUBO, HIROYA TAKEUCHI and YUKO KITAGAWA

Anticancer Research April 2020, 40 (4) 1921-1930; DOI: https://doi.org/10.21873/anticanres.14147
You have access
Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation
CHEN-YUAN LIN, HSIN-YUAN FANG, MING-YU LEIN, CHING-CHAN LIN, LI-YUAN BAI, MING-HUNG TSAI, CHI-CHING CHEN, TE-CHUN HSIEH, YAO-CHING WANG, JI-AN LIANG, CHIA-CHIN LI and CHUN-RU CHIEN

Anticancer Research April 2020, 40 (4) 2387-2392; DOI: https://doi.org/10.21873/anticanres.14208
You have access
Adjuvant Chemotherapy and Dose Escalation in Definitive Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
HYEON KANG KOH, YOUNGHEE PARK, TAERYOOL KOO, HAE JIN PARK, ME YEON LEE, AH RAM CHANG, SEMIE HONG and HOONSIK BAE

Anticancer Research March 2020, 40 (3) 1771-1778; DOI: https://doi.org/10.21873/anticanres.14131

Main menu

User menu

Search

esophageal squamous cell carcinoma

Pages